| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
BioGaia AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 123.40 |
| 52 Week High | SEK 136.60 |
| 52 Week Low | SEK 91.45 |
| Beta | 0.54 |
| 11 Month Change | -3.44% |
| 3 Month Change | 4.58% |
| 1 Year Change | 3.87% |
| 33 Year Change | 24.40% |
| 5 Year Change | 53.29% |
| Change since IPO | 1,462.03% |
Recent News & Updates
BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90
Apr 25
BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 09BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90
Mar 26BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90
Mar 09Recent updates
BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90
Apr 25BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 09BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90
Mar 26BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90
Mar 09BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90
Feb 24BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's
Feb 10Here's Why We Think BioGaia (STO:BIOG B) Might Deserve Your Attention Today
Nov 27Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)
Sep 13Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?
Jun 02A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)
Apr 27Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?
Jan 14Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?
Aug 26Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?
Jul 24Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)
Apr 02BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 21Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues
Feb 09BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's
Feb 07Some Shareholders May find It Hard To Increase BioGaia AB (publ)'s (STO:BIOG B) CEO Compensation This Year
Apr 29Key Things To Consider Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend
Mar 25The BioGaia (STO:BIOG B) Share Price Is Up 90% And Shareholders Are Holding On
Mar 04CEO & President Isabelle Valerie Ducellier Just Bought 8.2% More Shares In BioGaia AB (publ) (STO:BIOG B)
Feb 11Is BioGaia AB (publ)'s (STO:BIOG B) Latest Stock Performance A Reflection Of Its Financial Health?
Jan 26What Type Of Shareholders Own The Most Number of BioGaia AB (publ) (STO:BIOG B) Shares?
Jan 11
How Much Are BioGaia AB (publ) (STO:BIOG B) Insiders Taking Off The Table?
Dec 27Read This Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend
Dec 13BioGaia (STO:BIOG B) Shareholders Have Enjoyed A 57% Share Price Gain
Nov 28Shareholder Returns
| BIOG B | SE Biotechs | SE Market | |
|---|---|---|---|
| 7D | -0.7% | -0.9% | 0.2% |
| 1Y | 3.9% | 11.4% | 12.6% |
Return vs Industry: BIOG B underperformed the Swedish Biotechs industry which returned 16.4% over the past year.
Return vs Market: BIOG B underperformed the Swedish Market which returned 14.1% over the past year.
Price Volatility
| BIOG B volatility | |
|---|---|
| BIOG B Average Weekly Movement | 5.6% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 12.3% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: BIOG B has not had significant price volatility in the past 3 months.
Volatility Over Time: BIOG B's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 211 | Theresa Agnew | www.biogaia.com |
BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula.
BioGaia AB (publ) Fundamentals Summary
| BIOG B fundamental statistics | |
|---|---|
| Market cap | SEK 12.56b |
| Earnings (TTM) | SEK 371.25m |
| Revenue (TTM) | SEK 1.30b |
33.6x
P/E Ratio9.6x
P/S RatioIs BIOG B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOG B income statement (TTM) | |
|---|---|
| Revenue | SEK 1.30b |
| Cost of Revenue | SEK 346.97m |
| Gross Profit | SEK 953.51m |
| Other Expenses | SEK 582.25m |
| Earnings | SEK 371.25m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 23, 2024
| Earnings per share (EPS) | 3.68 |
| Gross Margin | 73.32% |
| Net Profit Margin | 28.55% |
| Debt/Equity Ratio | 0% |
How did BIOG B perform over the long term?
See historical performance and comparison